A phase I clinical trial assessing prophylactic infusion of donor CD45RA-negative memory - effector T cells into patients transplanted with hematopoietic stem cells from haploidentical donors after reduced intensity conditioning

This “allocated fund” from the Symphasis charitable umbrella foundation was awarded to Dr. Anne-Claire Mamez from the Geneva University Hospitals in April 2018 for four years.

News & Events

Posted on

Novelty in the field of oncology. The CHUV is testing a promising radiotherapy against cancer.

Read more
Posted on

Welcome to Prof. Christoph Merten, head of the biomedical microfluidics laboratory at AGORA, an essential link in the development of new drugs.

Read more
Posted on

The Pierre-François Leyvraz Award was created by the ISREC Foundation to honor Prof. Pierre-François Leyvraz’ commitment within its Foundation…

Read more
Posted on

The ISREC Foundation, celebrating its 56th anniversary this month, is developing its activities at the heart of the AGORA cancer research cluster. The…

Read more